Home Multicenter evaluation of the commutability of a potential reference material for harmonization of enzyme activities
Article
Licensed
Unlicensed Requires Authentication

Multicenter evaluation of the commutability of a potential reference material for harmonization of enzyme activities

  • Volkher Scharnhorst , Joke Apperloo , Henk Baadenhuijsen and Huib L. Vader
Published/Copyright: June 1, 2005

Abstract

Standardization of laboratory results allows for the use of common reference intervals and can be achieved via calibration of field methods with secondary reference materials. These harmonization materials should be commutable, i.e., they produce identical numerical results independent of assay principle or platform. This study assessed the commutability of a cryolyoprotectant-containing harmonization material, obtained from the Dutch Foundation for Quality Assessment in Clinical Laboratories, that is intended to harmonize measurements of enzyme activities within the Dutch project “Calibration 2000”. The catalytic concentrations of alkaline phosphatase, aspartate aminotransferase, alanine aminotransferase, lactate dehydrogenase, γ-glutamyltransferase and creatine kinase were analyzed in pooled patient sera and in the reference material in 14 laboratories. On liquid chemistry analyzers the harmonization material behaves like patient material. The enzyme activities measured in it fall on the regression lines calculated from activities measured in serum samples. For dry chemistry analyzers the activities of all enzymes measured in the harmonizator differ from the serum-based regression line. We show that this is due to the sucrose-containing cryolyoprotectant in the harmonization material. For each enzyme, correction factors were calculated that compensated for the bias and proved to be constant between reagent lots. Depending on the enzyme activity measured, application of these factors leads to 2- to 10-fold reduction of between-laboratory percentage coefficient of variation. Thus, additives to (potential) reference materials may alter their matrix in a way that interferes with analysis on certain test systems. The bias caused may be quantifiable and correctable. Establishment of correction factors leads to analytical uncertainties and costs. Therefore, matrix-based materials without additives should be selected as reference materials.


Present address: Clinical Chemistry and Hermatology Laboratory, Atrium Medical Center, P.O. Box 4446, 6401 CX Heerlen, The Netherlands; Corresponding author: Volkher Scharnhorst, Clinical Laboratory, Máxima Medical Center, Veldhoven, The Netherlands Fax: +31-45-5766973,

References

1 Kristiansen J, Christensen JM. Traceability and uncertainty in analytical measurements. Ann Clin Biochem 1998; 35:371–9.10.1177/000456329803500305Search in Google Scholar PubMed

2 Panteghini M, Ceriotti F, Schumann G, Siekmann L. Establishing a reference system in clinical enzymology. Clin Chem Lab Med 2001; 39:795–800.10.1515/CCLM.2001.131Search in Google Scholar PubMed

3 Siekmann L, Bonora R, Burtis CA, Ceriotti F, Clerc-Renaud P, Ferard G, et al. IFCC primary reference procedures for the measurement of catalytic activity concentrations of enzymes at 37°C. Part 1. The concept of reference procedures for the measurement of catalytic activity concentrations of enzymes. Clin Chem Lab Med 2002; 40:631–4.10.1515/CCLM.2002.109Search in Google Scholar PubMed

4 EU Lex. Directive 98/79 EC on in vitro diagnostic medical devices. Off J L 1998;331:1–37.Search in Google Scholar

5 Schumann G, Bonora R, Ceriotti F, Clerc-Renaud P, Ferrero CA, Ferard G, et al. IFCC primary reference procedures for the measurement of catalytic activity concentrations of enzymes at 37°C. Part 2. Reference procedure for the measurement of catalytic concentration of creatine kinase. Clin Chem Lab Med 2002; 40:635–42.10.1515/CCLM.2002.110Search in Google Scholar PubMed

6 Schumann G, Bonora R, Ceriotti F, Clerc-Renaud P, Ferrero CA, Ferard G, et al. IFCC primary reference procedures for the measurement of catalytic activity concentrations of enzymes at 37°C. Part 3. Reference procedure for the measurement of catalytic concentration of lactate dehydrogenase. Clin Chem Lab Med 2002; 40:643–8.10.1515/CCLM.2002.111Search in Google Scholar PubMed

7 Schumann G, Bonora R, Ceriotti F, Ferard G, Ferrero CA, Franck PF, et al. IFCC primary reference procedures for the measurement of catalytic activity concentrations of enzymes at 37°C. International Federation of Clinical Chemistry and Laboratory Medicine. Part 4. Reference procedure for the measurement of catalytic concentration of alanine aminotransferase. Clin Chem Lab Med 2002; 40:718–24.10.1515/CCLM.2002.124Search in Google Scholar PubMed

8 Schumann G, Bonora R, Ceriotti F, Ferard G, Ferrero CA, Franck PF, et al. IFCC primary reference procedures for the measurement of catalytic activity concentrations of enzymes at 37°C. International Federation of Clinical Chemistry and Laboratory Medicine. Part 5. Reference procedure for the measurement of catalytic concentration of aspartate aminotransferase. Clin Chem Lab Med 2002; 40:725–33.10.1515/CCLM.2002.125Search in Google Scholar PubMed

9 Schumann G, Bonora R, Ceriotti F, Ferard G, Ferrero CA, Franck PF, et al. IFCC primary reference procedures for the measurement of catalytic activity concentrations of enzymes at 37°C. International Federation of Clinical Chemistry and Laboratory Medicine. Part 6. Reference procedure for the measurement of catalytic concentration of gamma-glutamyl transferase. Clin Chem Lab Med 2002; 40:734–8.Search in Google Scholar

10 Siekmann L, Bonora R, Burtis CA, Ceriotti F, Clerc-Renaud P, Ferard G, et al. IFCC primary reference procedures for the measurement of catalytic activity concentrations of enzymes at 37°C. International Federation of Clinical Chemistry and Laboratory Medicine. Part 7. Certification of four reference materials for the determination of enzymatic activity of gamma-glutamyl transferase, lactate dehydrogenase, alanine aminotransferase and creatine kinase according to the IFCC reference procedure at 37 degrees C. Clin Chem Lab Med 2002; 40:739–45.10.1515/CCLM.2002.127Search in Google Scholar PubMed

11 Müller MM. Implementation of reference systems in laboratory medicine. Clin Chem 2000; 46:1907–9.10.1093/clinchem/46.12.1907Search in Google Scholar

12 Cobbaert C, Weykamp C, Baadenhuijsen H, Kuypers A, Lindemans J, Jansen R. Selection, preparation, and characterization of commutable frozen human serum pools as potential secondary reference materials for lipid and apolipoprotein measurements: study within the framework of the Dutch project “Calibration 2000”. Clin Chem 2002; 48:1526–38.10.1093/clinchem/48.9.1526Search in Google Scholar

13 Baadenhuijsen H, Steigstra H, Cobbaert C, Kuypers A, Weykamp C, Jansen R. Commutability assessment of potential reference materials using a multicenter split-patient-sample between-field-methods (twin-study) design: study within the framework of the Dutch project “Calibration 2000”. Clin Chem 2002; 48:1520–5.10.1093/clinchem/48.9.1520Search in Google Scholar

14 Franck PF, Steen G, Lombarts AJ, Souverijn JH, van Wermeskerken RK. Multicenter harmonization of common enzyme results by fresh patient-pool sera. Clin Chem 1998; 44:614–21.10.1093/clinchem/44.3.614Search in Google Scholar

15 Muller MM. Reference materials: general aspects and IFCC strategy. International Federation of Clinical Chemistry. Clin Biochem 1998; 31:433–6.Search in Google Scholar

Received: 2004-9-1
Accepted: 2004-9-7
Published Online: 2005-6-1
Published in Print: 2004-12-1

©2004 by Walter de Gruyter Berlin New York

Articles in the same Issue

  1. Contents
  2. Author Index
  3. Subject Index
  4. Hematopoietic cytokines as tumor markers
  5. The apoB/apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk
  6. Rapid combined genotyping of factor V, prothrombin and methylenetetrahydrofolate reductase single nucleotide polymorphisms using minor groove binding DNA oligonucleotides (MGB probes) and real-time polymerase chain reaction
  7. Methylenetetrahydrofolate reductase gene A222V polymorphism and risk of ischemic stroke
  8. Determination of asymmetric dimethylarginine (ADMA) using a novel ELISA assay
  9. The assessment of bone metabolism in female elite endurance athletes by biochemical bone markers
  10. Declines in serum free and bound choline concentrations in humans after three different types of major surgery
  11. Analysis of inflammatory response in human plasma samples by an automated multicapillary electrophoresis system
  12. Multicenter evaluation of the commutability of a potential reference material for harmonization of enzyme activities
  13. HDL and clinical and biochemical correlates in Italian non-smoker women
  14. Hyperhomocysteinaemia is associated with uveitis but not with deep venous thrombosis in Behçet's disease
  15. Production of gender-specific morning salivary cortisol reference intervals using internationally accepted procedures
  16. Concentrations of N-terminal pro-brain natriuretic peptide and troponin T in plasma of 75-year-old apparently healthy persons
  17. External Quality Assessment for biochemical markers of myocardial damage: an Italian experience
  18. Further evaluation of the immunonephelometric assay of soluble transferrin receptor and assessment of pediatric values in southern Italy
  19. Exercise raises serum heat-shock protein 70 (Hsp70) levels
  20. Hepatitis C-associated complement cold activation
  21. The relationship between cryoglobulins and HCV-RNA in the serum of patients infected with different HCV genotypes
  22. Artificial neural network-based algorithm for the evaluation of serum protein capillary electrophoresis
  23. State-of-the-art systematic error for therapeutic drug monitoring
  24. Peculiarities and problems with the EXCEL® F-test
  25. Questionable results – should EQA results be accepted as submitted or should ‘obvious mistakes’ be corrected?. Reply to Wood WG. Questionable results – who directs the EQAS organisers? CCLM 2004;42(9):1073
  26. Erratum
Downloaded on 15.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2004.261/html
Scroll to top button